Dudediligence.

Lantheus Holdings, Inc

LNTHNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Other eventsOct 2 →InsidersNo open-market buys or sales.→HoldersBlackRock 12.9%Farallon 8.6%Jupiter Topco 7.9%→PeersClosest companies: CATX, ALNY, AKTS→

From the filings

Figures

Revenue
$1.56Blast 12 months
Net income
$275.3Mlast 12 months
Operating cash flow
$407.7Mlast 12 months
Cash and equivalents
$593.3Mat the last balance sheet
Total debt
$571.1Mat the last balance sheet
Shares outstanding
65.3M shareson issue
Every year and quarter →